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A key limitation to the analysis of the immune response in man has been the 
difficulty of defining and characterizing the unique surface components of human 
lymphocyte subpopulations. Whereas specific lymphocyte differentiation antigens 
have been defined by heterologous antibodies from immune sera, many of the 
technical limitations of this approach can now be resolved by the generation of 
monoclonal antibodies with somatic cell hybridization techniques (1). We have 
therefore applied these techniques to study differentiation antigens on human T 
lymphocytes. 
In this report we define and characterize by a monoclonal antibody a surface 
antigen complex of 69,000 and 71,000 daltons, p69,71 (Leu 1), 1 that has a thymus- 
dependent distribution on normal lymphocytes, but shares determinants with leu- 
kemic cells from patients with B-type chronic lymphatic leukemia. The distribution 
and molecular nature of p69,71 suggest that this complex may be related to the GLX 
system in the mouse (2). 
Materials and Methods 
Production of Monoclonal Antibody 
IMMUNIZATION AND SOMATIC CELL HYBRIDIZATION. BALB/c mice were immunized subcuta- 
neously with 1 × l0 T sheep erythrocyte (SRBC)-rosetting human peripheral blood lymphocytes 
and boosted three times at 2-wk intervals. 3 d after the last immunization, the splenocytes were 
fused with P3 × 63 Ag-8 myeloma cells, and cultured in RPMI-1640 (Grand Island Biological 
Co., Grand Island, N. Y.) that contained 15% fetal calf serum (FCS) and hypoxanthine- 
aminiopterine-thymidine following the procedure developed by K6hler and Milstein (1). 
SELECTION AND CLONING OF HYBRIDIZED CELLS. Approximately 10-14 d later, supernates 
were collected from wells with hybrid cell growth and tested for antibody specific to T cells by 
indirect immunofiuorescent analysis as described below. Hybrids from wells that contained 
antibodies specific to peripheral T lymphocytes were harvested and cloned by a limiting- 
dilution method in the presence of feeder cells (3) and plated into a Linbro 96-well fiat-bottom 
tissue culture plate (Linbro Chemical Co., Hamden, Conn.) for subsequent screening and 
recloning. 
NUDE MICE SERUM THAT CONTAINED MONOCLONAL ANTIBODY. After recloning positive hybrids 
8-10 times, 1 x l07 hybrid cells were implanted subcutaneously into nu/nu mice on a Swiss 
strain background. Sera were obtained from these tumor-bearing mice ~3 wk later. 
* Supported in part by National Institutes of Health grants CA-08747 and AI-11843, the Zelda Radow 
Weintraub Cancer Fund, The Sherman-Fairchild Foundation, and the Arthur J. and Lcslie Lcvine 
Laboratory Fund. 
t In developing a terminology for a series of leukocyte differentiation antigens, this antigen has bccn 
designated leukocyte determinant number l (Lcu 1). 
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Specificity Analysis of the Monoclonal Antibody 
ISOLATION OF T LYMPHOCYTE POPULATION.  Mononuclear cells  were  separated  from  fresh 
heparinized blood of normal individuals by Ficoll (Pharmacia Fine Chemicals, Div. of Phar- 
macia, Inc., Piscataway, N.J.) -Hypaque (Winthrop Laboratories, New York) density gradient 
centrifugation. T  cells were isolated from other mononuclear cells by a  two-step process  that 
involved passage over nylon-wool  columns followed by E-rosette formation and density gradient 
centrifugation (4). 
ISOLATION OF MONOCYTES.  Monocytes were isolated by plating peripheral blood mononu- 
clear cells at a density of 5 ×  106/ml  in RPMI-1640 that contained 10% FCS over glass Petri 
dishes for 2 h. The nonadherent cells were removed by vigorous lavage, and the adherent cells 
are recovered after incubation for  1 h at 37°C in medium that contained 0.1% EDTA. Greater 
than 90% of these cells had the morphological characteristics of monocytes or macrophages. 
ISOLATION OF a CELLS.  Lymphocytes depleted of phagocytic cells by iron carbonyl treatment 
were brought to a concentration of 10-20 ×  106/ml and mixed at a 1  : 1 vol with a 5% suspension 
of neuraminidase-treated SRBC (4). The non-E-rosette-forming  cells  (B cells) were separated 
from the E-rosette-forming cells on Ficoll-Hypaque gradients. 
CYTOFLUOROGRAPHIC ANALYSIS.  Cytofluorographic analysis of all cell populations was per- 
formed  by  indirect  immunofluorescence with  fuorescent-conjugated F(ab')2  fragments  of 
affinity-purified goat anti-mouse IgG (G/M FITC) on a cytofluorograph (model FC200-4800 
A50, Ortho Instruments, Westwood, Mass.)  as previously described (5). 
In brief, 5 ×  105 cells were  treated with 0.15  ml of serum from mice bearing the a-Leu  1- 
secreting tumors at a 1:104 dilution, incubated at 4°C for 1 h, and washed twice. The cells were 
then mixed with 0.15 ml of G/M FITC at a  1:20 dilution for 1 h, washed three times, and then 
analyzed on the cytofluorograph. Background staining was obtained by using a serum from a 
nude mouse that was tumor free. 
Biochemical Analysis of the Target Antigen 
IODINATION OF THE CELL SURFACE.  A modification of the method of Marchalonis et al.  (6) 
was used to iodinate the surface as described previously (7). 
IMMUNOPRECIPITATION.  For immunoprecipitation  experiments, 100 #1 of the tumor-bearing 
nude mouse serum at a  1:103 dilution was incubated for 30 min at room temperature with  1 
×  107 125I-iodinated cells followed by two washes  in phosphate-buffered saline. The antibody- 
bound radioiodinated cells were lysed with 0.5 ml of 0.5% nonidet P-40 (NP-40)  (Shell Chemical 
Co., New York) in 10 mM Tris-HCl buffer (pH 8.0) that contained 10 mM iodoacetamide and 
then spun at 3,000 rpm for  10 rain to remove the nuclear debris. F(ab')2 fragments of affinity 
column purified goat  antimouse IgG reagent were coupled to cyanogen bromine-activated 
Sepharose 4B gel  (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.) at 3 mg/ml gel and 
used to bring down the antibody-bound,  radiolabeled surface antigens. The immunoprecipitates 
were then washed twice with buffer that contained 10 mM Tris HC1 (pH 8.0), 0.5 M LiC1, and 
0.1% NP-40 followed by a third wash with the same buffer that contained 0.1% sodium dodecyl 
sulfate (SDS). The bound 125I-labeled surface antigens were eluted by boiling the beads with 
4M  urea  and  2%  SDS  in 0.1  M  Tris  HCI  (pH  8.0) buffer and electrophoresed  on  SDS- 
polyacrylamide gels as described by Laemmli (8)  with  1.5-ram-thick slab gels with a  5-20% 
gradient of acrylamide. 
Results and Discussion 
Mouse splenocyte-myeloma  cell hybrids that produced antibodies that reacted with 
normal T  but not B cells were screened by indirect immunofluorescent analysis on a 
cytofluorograph. One such hybrid, which produced an antibody that reacted with the 
majority of SRBC-rosetting cells,  was  cloned  8-10  times  in  vitro  and  implanted 
subcutaneously into a  nude mouse. The resulting high-titered antiserum was shown 
to recognize a  p69,71  by immunoprecipitation experiments. This was performed by 
harvesting T  cells that were stimulating in culture for 5 d  with concanavalin A  (Con 
A)  and surface labeling the cells with ~25I by the lactoperoxidase-catalyzed reaction. WANG ET AL.  BRIEF DEFINITIVE REPORT  1541 
Fro.  1.  Autoradiographs of SDS gels (5-20%) of immunoprecipitates  prepared from NP-40 lysates 
of surface-radioiodinated Con A-activated (15 #g/106 cells per ml) T cell blasts. (a) Total cell lysate 
of the T cell blasts; (b) immunoprecipitate with a nude mouse serum with monoclonal antibody 
against human T cells; (c) immunoprecipitate with a control serum from a tumor-free nude mouse; 
(d) specific nude mouse serum from (b) was reacted with an excess of FCS before the incubation 
with the Con  A-activated T  cell blasts  for immunoprecipitation.  The position of the molecular 
weight (MW) markers is shown at the left: phosphorylase b 94,000; bovine serum albumin 67,000; 
ovalbumin 43,000; carbonic anhydrase 30,000; soybean trypsin inhibitor 20,100; and a-lactalbumin 
14,400. 
The cells were reacted with specific antibody, washed, and lysed with NP-40 detergent. 
The  immune  complexes  in  the  lysate were  absorbed onto  Sepharose  CL-4B  beads 
that  had  been  coupled with  F(ab')z fragments  of goat-antimouse  IgG reagent,  and 
analyzed by SDS-polyacrylamide gel electrophoresis. 
Under nonreducing conditions, the  total cell lysate of the Con  A-activated blasts 
gave more than 40 discernible bands that ranged from 5,000  to 220,000  dahons  (Fig. 
1 a).  The  immunoprecipitate  performed  with  the  monoclonal  antibody  gave  two 
distinct bands with molecular weights of 69,000  and  71,000  daltons  (Fig.  1 b).  As a 
control, a  normal nude mouse serum  did not precipitate any discernible component 
(Fig. 1 c). To exclude the possibility that the defined antigen was a component of FCS 
that had been passively absorbed onto the cells, the antibody was first incubated with 
an excess of FCS before reaction with the labeled cells as shown  in  Fig.  1 d.  Similar 
results were obtained with other positive target cells. 
The  specificity of the a-Leu  1 nude  mouse serum  was studied by indirect immu- 
no  fluorescence  on  a  cytofluorograph  with  techniques  that  have  been  previously 
described  (5).  Background  reactivity  was  assessed  by  using  a  serum  at  the  same 
dilution  (1:104)  from  a  tumor-free  animal  of the  same strain.  Fig.  2A  and  B  show 
representative binding curves of the a-Leu  1 serum and a  normal nude mouse serum 1542  WANG  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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Fro.  2.  Cytofluorograph analysis of indirect immunofluorescent staining of human lymphoid cells 
with specific nude mouse serum (Leu  1) at a  l:10,000 dilution (  ) or with control nude mouse 
serum (...).  10,000 cells were analyzed per sample. (A) E-rosette-positive peripheral blood lympho- 
cytes;  (B)  E-rosette-negative tonsillar lymphoeytes;  (C)  cells from a  patient with CLL  that  were 
positive with sIg and Ia antigen. The abscissa and ordinate record the number of cells and the 
fluorescence intensity per cell, respectively. 
reacted with peripheral blood T  cells, and with tonsillar B cells. As can be seen, the 
great majority of T  cells exhibited binding to a-Leu 1 above background. In contrast, 
B cells did not fluoresce above a normal serum control. 
As shown in Table I, 80-95% of SRBC-rosetting cells from the peripheral blood of 
20 normal individuals and >95% of thymocytes from 5 children  undergoing cardiac 
surgery were found to express the Leu  1 antigen.  Ongoing studies in our laboratory 
(Memorial  Sloan-Kettering Cancer Center,  New York)  indicate  that  the  5-20%  E- 
rosette-positive, Leu  1-negative cells do not express other thymus-dependent surface 
antigens. This finding suggests that t~-p69,71  defines the entire population  of circu- 
lating thymus-derived lymphocytes, and that some cells of a  non-thymic origin may 
carry the receptor for SRBC  (9). 
Data presented  in Table I  also indicate that a-Leu  1 does not react with normal 
lymphoid or hematopoietic cells that do not carry thymus-dependent markers. Thus, 
bone marrow cells,  monocytes, and  B  cells  from the  peripheral  blood,  tonsils,  and 
spleen  were  found  to be unreactive  with  c~-Leu  1.  Splenocytes were obtained  from 
patients with  Hodgkin's disease  that  had  been splenectomized  for staging.  Spleens 
that were pathologically positive for Hodgkin's disease were not included. 
Because of the demonstration  that a-Leu  1 was unreactive with normal B cells, it 
was surprising to find that this antibody reacted with Ig  + cells from 11 of 14 patients 
examined who had the clinical diagnosis of chronic lymphatic leukemia (CLL)  (Fig. 
2  C;  and  Table  I).  It  should  be  mentioned  that  the  great  majority  of cells  from 
patients with CLL have several characteristics that indicate that the malignant cells 
are of B cell origin. These include  surface markers characteristic of B  cells and  the 
capacity to differentiate into plasma cells under certain conditions (10).  Furthermore, 
none of the  14 cases examined in  this report reacted with monoclonal antibodies to 
thymus-dependent antigens, includingTH2  (5)  (data not shown). The possibility that 
the  expression  of Leu  1 by surface  (s)Ig  +  CLL  cells  resulted  from  transformation 
events  that  can  also  be  triggered  in  normal  B  cells  seems  unlikely  in  view  of the 
demonstration that Epstein-Barr virus (EBV)-infected B cell lymphoblasts were Leu 
1 negative (Table I). 
An alternative explanation of our results lies in the possibility that CLL represents 
a  malignancy of a  small subpopulation  of Leu  1-positive B  lymphocytes. However, 
this  does  not  seem  likely  in  light  of the  demonstration  that  this  subset  was  not WANG  ET  AL.  BRIEF  DEFINITIVE  REPORT  1543 
TABLE  I 
Reactivity of a-Leu 1 with Subpopulations of Lymphoid Cells by Immunofluorescent Analysis 
Cell source  Purified cell population  Percentage of positive cells 
PBL (20/20)* 
Tonsil (5/5) 
Spleen (4/4)§ 
Bone marrow (5/5) 
Thymocytes (5/5) 
Chronic  lymphocytic  leu- 
kemic cells (11/14) 
B  lymphoblastoid cell lines 
(lO/lO)ll 
E-RFC:~ enriched 
E-RFC depleted 
E-RFC depleted 
E-RFC depleted 
E-RFC depleted 
% 
80-95 
<5 
<5 
<5 
<5 
>95 
Positive with variable intensity 
Negative 
* 20 of 20 samples analyzed. 
:~ SRBC E-rosette-forming cells. 
§ Spleens obtained from patients with Hodgkin's disease that were not pathologically involved. 
[I Established in culture from normal PBL by transformation with EBV. 
detectable in the blood, tonsils, spleen, or bone marrow. Furthermore, these findings 
are consistent with the results of other studies that demonstrate that T  cells and sIg  + 
CLL cells share surface markers not  found on normal B cells. These include deter- 
minants  defined by heterologous anti-human  T  cell sera  (11),  receptors for Helix 
pomatia agglutinin  (12), and receptors for IgM  (13). Our  findings, therefore, raise 
questions regarding the classification of certain human lymphocyte surface antigens 
as markers of particular differentiation pathways, because induction of the determi- 
nant recognized by a-Leu 1 seems to take place under at least one set of pathological 
conditions outside the thymic environment. 
Finally,  it  is  relevant  to  our  studies  that  malignant  transformation  of murine 
lymphocytes may be associated with  the induction of membrane alloantigens that 
have a  normal tissue distribution that  is restricted by either strain phenotype or by 
cell  lineage  (14).  The  mouse  Gtx system  exemplifies such  an  antigen  because  its 
distribution on normal lymphoid cells is restricted to thymus-dependent lymphocytes 
of certain strains, but it is found on both thymic and nonthymic leukemias of Gix  + 
and Gix- strains (2). It is also notable that Gtx is associated with a membrane complex 
of 69,000 and 71,000 daltons and that this complex shares biochemical and antigenic 
properties with  the  major glycoprotein component  for the  murine  leukemia  virus 
envelope (15-17). We are therefore investigating a  possible relationship between the 
human p69,71 complex and the murine Gxx system. 
Summary 
In the course of generating monoclonal antibodies to human  thymus-dependent 
differentiation antigens, we were able to define specificities shared by T  cells and by 
cells  from patients  with  chronic  lymphatic  leukemia  that  were  not  detectable  on 
normal  B  cells.  In  particular,  one  of these  antibodies  was  reactive  by  indirect 
immunofluorescence with >95% of the thymocytes and 80-95% of nonadherent sheep 
erythrocyte-rosetting peripheral blood lymphocytes (PBL), but was unreactive with 
normal B cells or cell lines derived from PBL by Epstein-Barr virus transformation. 
However, the leukemic cells from  11  of 14 patients with  B-type chronic lymphatic 
leukemia were found to express detectable concentrations of this surface determinant. 
The target antigen recognized by this monoclonal antibody was shown by immu- 1544  WANG ET  AL.  BRIEF DEFINITIVE REPORT 
noprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis to be 
a  p69,71  complex. Our findings suggest a  possible relationship between  this antigen 
and the previously described Gtx system in the mouse. 
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